Research summary
Berberine and Cholesterol
Quick answer
Berberine is a plant compound that has been studied for its effects on blood lipids. Meta-analyses pooling randomized controlled trials have linked oral berberine, typically taken at around 1000 to 1500 mg per day, with reductions in total cholesterol, LDL cholesterol, and triglycerides compared with control. The underlying trials were often of limited methodological quality, so these associations should be read with that limitation in mind.[1], [2]
Limitations of the evidence
The authors of these meta-analyses noted that many of the included randomized trials were of limited methodological quality, which constrains how strongly the lipid findings can be interpreted. Much of the data comes from adults with type 2 diabetes or hyperlipidemia, so the results may not extend to other groups. These observations describe averaged trial results and are not medical advice; decisions about managing cholesterol should involve a qualified health professional.[1], [2]
What does the evidence support?
Read each finding with its qualification. These are source-supported statements, not a ranking of products or personal treatment advice.
| Finding and qualification | References |
|---|---|
| In meta-analyses of randomized trials, oral berberine at roughly 1000-1500 mg per day (commonly 500 mg two to three times daily) was associated with reductions in total cholesterol compared with control. in adults with type 2 diabetes or hyperlipidemia, at roughly 1000-1500 mg per day; pooled trials were of limited methodological quality | [1], [2] |
| Pooled randomized-trial data link oral berberine, typically around 1000-1500 mg per day, with lower LDL cholesterol relative to control groups. in adults with type 2 diabetes or hyperlipidemia, at roughly 1000-1500 mg per day; effect size is modest and based on limited-quality trials | [1], [2] |
| Meta-analyses also associate oral berberine at roughly 1000-1500 mg per day with reductions in triglycerides compared with control. in adults with type 2 diabetes or hyperlipidemia, at roughly 1000-1500 mg per day; based on pooled trials of limited methodological quality | [1], [2] |
What the pooled evidence shows
Two meta-analyses of randomized controlled trials examined berberine's effect on blood lipids. In one analysis of 46 trials in adults with type 2 diabetes, berberine taken alone or alongside standard therapy was associated with reductions in total cholesterol and LDL cholesterol relative to control groups. An earlier meta-analysis of 27 trials in people with diabetes, hyperlipidemia, or hypertension similarly found that adding berberine to lifestyle measures or to lipid-lowering drugs was associated with lower total cholesterol and LDL cholesterol.[1], [2]
Both analyses also reported reductions in triglycerides with berberine compared with control, and increases in HDL cholesterol. In one head-to-head comparison, berberine and conventional lipid-lowering drugs did not differ significantly for total and LDL cholesterol, while berberine appeared more favorable for triglycerides.[1], [2]
Doses studied
Across the pooled trials, berberine was generally given by mouth in divided doses, commonly around 500 mg two to three times daily, corresponding to roughly 1000 to 1500 mg per day. The lipid associations described here reflect that range and the populations studied, mainly adults with type 2 diabetes or elevated blood lipids.[1], [2]
Do lower LDL and triglycerides prove fewer heart attacks?
The reviews measured lipid markers: total cholesterol, LDL cholesterol, and triglycerides. Lower values in these trials do not by themselves establish fewer cardiovascular events or prove equivalence to a prescribed lipid-lowering treatment. The populations commonly had diabetes or hyperlipidemia, and the underlying trials were of limited methodological quality.[1], [2]
When a product cites the 1,000–1,500 mg daily range, check whether it is describing the same studied preparation and population. A familiar dose on the front label cannot resolve uncertainty about the evidence or medication interactions. These results are a reason to discuss the research with a clinician, not to stop a therapy with established clinical-outcome evidence.[1], [2], [3]
References
- The Effect of Berberine on Metabolic Profiles in Type 2 Diabetic Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.. Oxidative medicine and cellular longevity. 2021. Systematic review and meta-analysis View source →
- Meta-analysis of the effect and safety of berberine in the treatment of type 2 diabetes mellitus, hyperlipemia and hypertension.. Journal of ethnopharmacology. 2015. Systematic review and meta-analysis View source →
- Berberine and Weight Loss: What You Need To Know. NIH National Center for Complementary and Integrative Health. Retrieved 2026-09-09. Government health fact sheet View source →
Frequently asked questions
Does berberine lower cholesterol?
Meta-analyses of randomized trials associate oral berberine with lower total cholesterol, LDL cholesterol, and triglycerides in adults with type 2 diabetes or hyperlipidemia. The trials were often of limited methodological quality and do not establish berberine as a replacement for prescribed lipid-lowering treatment.
Sources: The Effect of Berberine on Metabolic Profiles in Type 2 Diabetic Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.; Meta-analysis of the effect and safety of berberine in the treatment of type 2 diabetes mellitus, hyperlipemia and hypertension.
Read the full FAQ and limitations →